Breaking News Instant updates and real-time market news.

CRBP

Corbus Pharmaceuticals

$7.02

0.15 (2.18%)

12:50
10/05/16
10/05
12:50
10/05/16
12:50

Corbus soars after analyst says buy ahead of data, eyes potential double

Clinical-stage drug developer Corbus Pharmaceuticals (CRBP) soared Wednesday after research firm Cantor Fitzgerald started coverage of the stock with a $17 price target -- more than double its $7 closing price on Tuesday -- on the firm's conviction in upcoming results for the company's anti-inflammatory therapy Resunab. CANTOR SEES MULTIPLE INFLECTION POINTS: Cantor Fitzgerald analyst Elemer Piros initiated coverage of Corbus with a Buy rating and $17 price target. Piros sees the inflammation and fibrosis researcher achieving three inflection points over the next year, beginning with data presentations in November on its lead candidate Resunab. In pre-clinical models, the drug showed an encouraging ability to restore the body's anti-inflammatory processes, and Corbus is set to unveil initial efficacy results in diffuse cutaneous systemic sclerosis in November, cystic fibrosis in January, and dermatomyositis in the second half of 2017. Piros also notes that Corbus has filed patents for an ultrapure formulation of Resunab that could extend patent protection until 2033. The analyst estimates a $3B combined market potential for the three orphan indications, and he models their risk-adjusted present value at more than $700M, yielding his $17 twelve-month price target. PRICE ACTION: Shares of Corbus Pharmaceuticals have soared 30% to $9.11. Year-to-date the stock, which closed at $1.61 per share on January 4, has advanced by about 450%.

CRBP Corbus Pharmaceuticals
$7.02

0.15 (2.18%)

09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.

TODAY'S FREE FLY STORIES

14:40
04/27/17
04/27
14:40
04/27/17
14:40
General news
Canada Industrial Product Price Index Preview »

Canada Industrial Product…

SNCR

Synchronoss

$24.62

-0.02 (-0.08%)

14:38
04/27/17
04/27
14:38
04/27/17
14:38
Downgrade
Synchronoss rating change  »

Synchronoss downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

14:36
04/27/17
04/27
14:36
04/27/17
14:36
General news
S&P flat, Nasdaq higher as investors brace for tech earnings barrage »

Stocks are little changed…

FSLR

First Solar

$28.99

1.45 (5.27%)

14:35
04/27/17
04/27
14:35
04/27/17
14:35
Upgrade
First Solar rating change  »

First Solar upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 02

    May

  • 03

    May

  • 17

    May

PRTY

Party City

$16.25

1.5 (10.17%)

14:34
04/27/17
04/27
14:34
04/27/17
14:34
Periodicals
Party City looking into sale of the company, Reuters reports »

Party City is looking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

MU

Micron

$26.79

-0.2 (-0.74%)

14:33
04/27/17
04/27
14:33
04/27/17
14:33
Recommendations
Micron analyst commentary  »

Micron new CEO hire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 15

    May

  • 30

    May

  • 31

    May

  • 01

    Jun

  • 07

    Jun

BIIB

Biogen

$279.98

-6.91 (-2.41%)

, AMGN

Amgen

$164.61

-0.09 (-0.05%)

14:31
04/27/17
04/27
14:31
04/27/17
14:31
Earnings
On The Fly: What to watch in biotech earnings reports »

The earnings season for…

BIIB

Biogen

$279.98

-6.91 (-2.41%)

AMGN

Amgen

$164.61

-0.09 (-0.05%)

CELG

Celgene

$125.20

-0.32 (-0.25%)

GILD

Gilead

$68.22

1.1 (1.64%)

IONS

Ionis Pharmaceuticals

$46.96

-0.92 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 09

    May

  • 24

    May

  • 31

    May

  • 19

    Jul

  • 14

    Aug

WFT

Weatherford

$5.49

-0.25 (-4.36%)

14:31
04/27/17
04/27
14:31
04/27/17
14:31
Options
Weatherford with hefty option blocks ahead of earnings »

Weatherford with hefty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 15

    Jun

$NSD

NASDAQ Market Internals

14:17
04/27/17
04/27
14:17
04/27/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$87.54

-0.895 (-1.01%)

14:17
04/27/17
04/27
14:17
04/27/17
14:17
Periodicals
Breaking Periodicals news story on JPMorgan »

JPMorgan won't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 19

    May

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

$NYE

NYSE Market Internals

14:16
04/27/17
04/27
14:16
04/27/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

WEX

$102.16

-4.69 (-4.39%)

14:14
04/27/17
04/27
14:14
04/27/17
14:14
Upgrade
WEX rating change  »

WEX upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

NBLX

Noble Midstream

$48.99

-0.715 (-1.44%)

14:12
04/27/17
04/27
14:12
04/27/17
14:12
Hot Stocks
Noble Midstream boosts quarterly distribution 4.7% »

Noble Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 11

    May

SBUX

Starbucks

$61.56

0.6 (0.98%)

14:11
04/27/17
04/27
14:11
04/27/17
14:11
Earnings
On The Fly: What to watch in Starbucks earnings report »

Starbucks (SBUX) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 24

    May

JCP

J.C. Penney

$5.45

-0.07 (-1.27%)

14:11
04/27/17
04/27
14:11
04/27/17
14:11
Options
Doom puts opened in JC Penney as shares fall to 52-week lows »

Doom puts opened in JC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 19

    May

  • 24

    May

GRUB

GrubHub

$41.43

6.41 (18.30%)

, YELP

Yelp

$35.79

1.21 (3.50%)

14:03
04/27/17
04/27
14:03
04/27/17
14:03
Hot Stocks
GrubHub soars after showing eye-popping user growth »

Shares of GrubHub (GRUB)…

GRUB

GrubHub

$41.43

6.41 (18.30%)

YELP

Yelp

$35.79

1.21 (3.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 11

    May

  • 16

    May

  • 24

    May

  • 25

    May

  • 05

    Jun

  • 08

    Jun

DISH

Dish

$63.30

0.76 (1.22%)

13:54
04/27/17
04/27
13:54
04/27/17
13:54
Hot Stocks
Dish appoints Andy LeCuyer to lead programming group »

DISH announced that Andy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

ALKS

Alkermes

$57.13

0.13 (0.23%)

13:46
04/27/17
04/27
13:46
04/27/17
13:46
Recommendations
Alkermes analyst commentary  »

JPMorgan keeps Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

INTC

Intel

$36.93

0.06 (0.16%)

, MBLY

Mobileye

$61.94

0.115 (0.19%)

13:44
04/27/17
04/27
13:44
04/27/17
13:44
Earnings
On The Fly: What to watch for in Intel's earnings report »

Intel (INTC) is scheduled…

INTC

Intel

$36.93

0.06 (0.16%)

MBLY

Mobileye

$61.94

0.115 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 15

    May

  • 30

    May

  • 01

    Jun

ALKS

Alkermes

$57.13

0.13 (0.23%)

13:42
04/27/17
04/27
13:42
04/27/17
13:42
Recommendations
Alkermes analyst commentary  »

Jefferies trims Alkermes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

BIDU

Baidu

$186.67

-0.32 (-0.17%)

13:40
04/27/17
04/27
13:40
04/27/17
13:40
Technical Analysis
Baidu technical commentary ahead of earnings news, technical pattern »

There is a symmetrical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SNCR

Synchronoss

$24.62

-0.02 (-0.08%)

13:36
04/27/17
04/27
13:36
04/27/17
13:36
Downgrade
Synchronoss rating change  »

Synchronoss downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

GNC

GNC Holdings

$8.16

-0.15 (-1.81%)

13:36
04/27/17
04/27
13:36
04/27/17
13:36
Options
GNC Holdings put volume heavy and directionally bearish »

Bearish flow noted in GNC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

C

Citi

$59.50

-0.44 (-0.73%)

, HMC

Honda

$28.99

-0.09 (-0.31%)

13:35
04/27/17
04/27
13:35
04/27/17
13:35
Hot Stocks
Citi Retail Services signs agreement with Honda Power Equipment »

Citi Retail Services (C)…

C

Citi

$59.50

-0.44 (-0.73%)

HMC

Honda

$28.99

-0.09 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 25

    Jul

BMRN

BioMarin

$96.07

1.88 (2.00%)

13:30
04/27/17
04/27
13:30
04/27/17
13:30
Hot Stocks
BioMarin expects Brineura to be available by early June »

BioMarin Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 04

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.